DRTS ▲ +0.8% - Alpha Tau Medical Ltd. $DRTS DRTSW - Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions Alpha Tau Medical completed patient enrollment in its multicenter IMPACT pilot study for Alpha DaRT, its targeted cancer therapy, ahead of schedule due to strong demand that led to multiple study expansions. The completion of enrollment in this pancreatic cancer study represents a key milestone that brings the company closer to generating clinical data on the treatment's efficacy, which likely drove the modest 0.8% gain today. 31-AUG-2026 08:02 AM ET